Oruka Therapeutics (NASDAQ:ORKA) Research Coverage Started at Wedbush
Wedbush initiated coverage on shares of Oruka Therapeutics (NASDAQ:ORKA – Free Report) in a research report released on Wednesday morning, Benzinga reports. The firm issued an outperform rating and a $40.00 target price on the stock. Oruka Therapeutics Stock Up 2.8 % Oruka Therapeutics stock opened at $24.99 on Wednesday. Oruka Therapeutics has a 52-week […]
More Stories
Stockman Wealth Management Inc. Has $15.24 Million Stock Holdings in Costco Wholesale Co. (NASDAQ:COST)
Stockman Wealth Management Inc. boosted its position in Costco Wholesale Co. (NASDAQ:COST – Free Report) by 0.6% during the third...
McDonald’s Co. (NYSE:MCD) Shares Sold by Colonial River Investments LLC
Colonial River Investments LLC lessened its stake in shares of McDonald’s Co. (NYSE:MCD – Free Report) by 26.7% in the...
Kampmann Melissa S. Makes New Investment in Oracle Co. (NYSE:ORCL)
Kampmann Melissa S. acquired a new stake in Oracle Co. (NYSE:ORCL – Free Report) during the third quarter, according to...
Comparing JBDI Holdings Limited Ordinary Shares (NASDAQ:JBDI) and Greif (NYSE:GEF)
Greif (NYSE:GEF – Get Free Report) and JBDI Holdings Limited Ordinary Shares (NASDAQ:JBDI – Get Free Report) are both industrial...
Vanguard Growth ETF (NYSEARCA:VUG) Shares Sold by Advantage Trust Co
Advantage Trust Co cut its position in shares of Vanguard Growth ETF (NYSEARCA:VUG – Free Report) by 0.8% in the...
GSG Advisors LLC Purchases 315 Shares of Tesla, Inc. (NASDAQ:TSLA)
GSG Advisors LLC lifted its position in Tesla, Inc. (NASDAQ:TSLA – Free Report) by 21.1% during the third quarter, Holdings...